首页> 外文期刊>Bioorganic and medicinal chemistry >Design, synthesis and binding at cloned muscarinic receptors of N-(5-(1'-substituted-acetoxymethyl)-3-oxadiazolyl) and N-(4-(1'-substituted-acetoxymethyl)-2-dioxolanyl) dialkyl amines.
【24h】

Design, synthesis and binding at cloned muscarinic receptors of N-(5-(1'-substituted-acetoxymethyl)-3-oxadiazolyl) and N-(4-(1'-substituted-acetoxymethyl)-2-dioxolanyl) dialkyl amines.

机译:N-(5-(1'-取代-乙酰氧基甲基)-3-恶二唑基)和N-(4-(1'-取代-乙酰氧基甲基)-2-二氧戊环)二烷基胺的克隆毒蕈碱受体的设计,合成和结合。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Few muscarinic antagonists differentiate between the M4 and M2 muscarinic receptors. In a structure activity study, aimed at discovering leads for the development of a M4 muscarinic receptor-selective antagonist, we have synthesized and tested at cloned muscarinic receptors the binding of a group of dioxolane- or oxadiazole-dialkyl amines, and compared them to our compound 1, which contains the furan nucleus. Although none of these agents were particularly potent at M4 receptors (Kd values were typically 30-70 nM), furan derivatives (-)1 and (+)1 were significantly more potent at M4 receptors than at M2 receptors (approximately 3- and 4-fold, respectively). The dioxolane derivatives 12b and 12c were more than 10-fold selective for the M4 versus the M2 receptors, while the dioxolane derivative 12e was 15-fold more potent at M4 receptors than for M2 receptors. However, these agents bound to M3 receptors with potencies like that for the M4 receptor, so they are not M4-selective. The M4/M2 relative selectivities of some of our compounds are similar to the better hexahydrosiladifenidol derivatives, and may provide some important structural clues for the development of potent and selective M4 antagonists.
机译:很少有毒蕈碱拮抗剂可以区分M4和M2毒蕈碱受体。在一项结构活性研究中,旨在发现导致M4毒蕈碱受体选择性拮抗剂发展的先导,我们在克隆的毒蕈碱受体上合成并测试了一组二氧戊环或恶二唑二烷基胺的结合力,并将其与我们的比较化合物1,其中含有呋喃核。尽管这些试剂都不对M4受体特别有效(Kd值通常为30-70 nM),但呋喃衍生物(-)1和(+)1对M4受体的效力比对M2受体的效力大得多(大约3-和4 -倍)。与M2受体相比,二氧戊环衍生物12b和12c对M4受体的选择性高10倍以上,而对M4受体的二氧戊环衍生物12e的效力比对M2受体高15倍。但是,这些试剂与M3受体的结合力类似于M4受体,因此它们不是M4选择性的。我们某些化合物的M4 / M2相对选择性类似于更好的六氢硅二苯胺醇衍生物,并且可能为开发有效和选择性的M4拮抗剂提供一些重要的结构线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号